Beta-Blockers Post-MI with Preserved Ejection Fraction — Research & Evidence

Q: What does the research say about Beta-Blockers Post-MI with Preserved Ejection Fraction?

The scientific consensus on Beta-Blockers Post-MI with Preserved Ejection Fraction is emerging. Emerging evidence with 100 primary claims Based on 100 analyzed claims: 0 agreements and 0 contradictions.

What does the research say about Beta-Blockers Post-MI with Preserved Ejection Fraction?

Emerging pathwayBased on 100 claims (0 agreements, 0 contradictions)

Emerging evidence with 100 primary claims

New research on Beta-Blockers Post-MI with Preserved Ejection Fraction

Efficacy of Beta-blocker Therapy in Post-myocardial Infarction Patients with Preserved or Mildly Reduced Ejection Fraction: A Systematic Review and Meta-analysis

Journal of Cardiac Critical Care TSS — Mata E — Jul 2026

Beta‐Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta‐Analysis With Trial Sequential Analysis

European Journal of Clinical Investigation — Maremmani M — Jun 2026

Impact of beta-blockers on quality of life in patients with myocardial infarction without heart failure: a sub-study of the DANBLOCK-trial

European Journal of Preventive Cardiology — Rykind F — Jun 2026

Beta-blocker therapy and angina pectoris after myocardial infarction: a BETAMI-DANBLOCK substudy

European Journal of Preventive Cardiology — Kristensen A — Jun 2026

Beta-blockers after myocardial infarction with preserved ejection fraction: A meta-analysis with trial sequential analysis

Journal of the Renin-Angiotensin-Aldosterone System — Song Q — Jun 2026

Beta-blockers after myocardial infarction with preserved or mildly reduced ejection fraction: existing evidence, knowledge gaps, and an EF-stratified framework

Frontiers in Pharmacology — Zhao S — Apr 2026

Outcomes in the BETAMI-DANBLOCK trial compared with a Norwegian nationwide myocardial infarction population

European Heart Journal — Kristensen A — Apr 2026

Beta-Blocker Therapy After Myocardial Infarction: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials

International Journal of Molecular Sciences — Fusco S — Mar 2026

Guideline implications of REBOOT: beta-blockers therapy in post-MI patients with preserved LVEF

International Journal of Surgery — Nazir A — Jan 2026

β-Blockers After Myocardial Infarction in Patients With Preserved Ejection Fraction

JAMA Cardiology — Li L — Jan 2026

Baseline Ejection Fraction as a Modifier of Beta‐Blocker Therapeutic Effects in Post‐Acute Coronary Syndrome Patients With Non‐Reduced Ejection Fraction: A Systematic Review and Meta‐Analysis

Cardiovascular Therapeutics — Mirhosseini S — Jan 2026

Beta-blocker therapy after myocardial infarction with preserved LVEF (≥50%): a systematic review and Bayesian meta-analysis with time-to-event reconstruction

American Heart Journal Plus Cardiology Research and Practice — Al-Shammari A — Dec 2025

Stay current on Beta-Blockers Post-MI with Preserved Ejection Fraction

Follow this topic to get a weekly “what changed” evidence digest and alerts when journal clubs schedule sessions on it.

Evidence brief: Beta-Blockers Post-MI with Preserved Ejection Fraction

Beta-Blockers Post-MI with Preserved Ejection Fraction. This research cluster examines the efficacy and role of beta-blocker therapy in secondary prevention after myocardial infarction specifically in patients with preserved or mildly reduced left ventricular ejection fraction.

As of 2026-08-15, the scientific consensus on Beta-Blockers Post-MI with Preserved Ejection Fraction is emerging. Emerging evidence with 100 primary claims Based on 100 analyzed claims across Synapse's enriched corpus, the evidence shows.

This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/beta-blockers-post-mi-with-preserved-ejection-fraction.

Deterministic synthesis from Synapse's enriched corpus — 79 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.

What are the most important papers on Beta-Blockers Post-MI with Preserved Ejection Fraction?

Efficacy of Beta-blocker Therapy in Post-myocardial Infarction Patients with Preserved or Mildly Reduced Ejection Fraction: A Systematic Review and Meta-analysis

Journal of Cardiac Critical Care TSS — Mata E

Beta-Blocker Therapy After Myocardial Infarction: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials

International Journal of Molecular Sciences — Fusco S

Beta‐Blockers After Myocardial Infarction With Preserved and Mildly Reduced Ejection Fraction: A Meta‐Analysis With Trial Sequential Analysis

European Journal of Clinical Investigation — Maremmani M

Follow the latest Beta-Blockers Post-MI with Preserved Ejection Fraction research

Explore every Beta-Blockers Post-MI with Preserved Ejection Fraction paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.

Search Beta-Blockers Post-MI with Preserved Ejection Fraction papers